235 related articles for article (PubMed ID: 15542618)
1. Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function.
Teschemacher AG; Wang S; Lonergan T; Duale H; Waki H; Paton JF; Kasparov S
Exp Physiol; 2005 Jan; 90(1):61-9. PubMed ID: 15542618
[TBL] [Abstract][Full Text] [Related]
2. Differences in transductional tropism of adenoviral and lentiviral vectors in the rat brainstem.
Duale H; Kasparov S; Paton JF; Teschemacher AG
Exp Physiol; 2005 Jan; 90(1):71-8. PubMed ID: 15542614
[TBL] [Abstract][Full Text] [Related]
3. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S
Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619
[TBL] [Abstract][Full Text] [Related]
4. Cell-selective viral gene delivery vectors for the vasculature.
Baker AH; Kritz A; Work LM; Nicklin SA
Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
[TBL] [Abstract][Full Text] [Related]
5. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
[TBL] [Abstract][Full Text] [Related]
6. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G
J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840
[TBL] [Abstract][Full Text] [Related]
7. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
8. Biology and application of alphaviruses in gene therapy.
Lundstrom K
Gene Ther; 2005 Oct; 12 Suppl 1():S92-7. PubMed ID: 16231060
[TBL] [Abstract][Full Text] [Related]
9. Surface-engineering of lentiviral vectors.
Verhoeyen E; Cosset FL
J Gene Med; 2004 Feb; 6 Suppl 1():S83-94. PubMed ID: 14978753
[TBL] [Abstract][Full Text] [Related]
10. Neuronal gene transfer by baculovirus-derived vectors accommodating a neurone-specific promoter.
Li Y; Yang Y; Wang S
Exp Physiol; 2005 Jan; 90(1):39-44. PubMed ID: 15542616
[TBL] [Abstract][Full Text] [Related]
11. Alphaviral cytotoxicity and its implication in vector development.
Rhême C; Ehrengruber MU; Grandgirard D
Exp Physiol; 2005 Jan; 90(1):45-52. PubMed ID: 15542620
[TBL] [Abstract][Full Text] [Related]
12. Imaging living central neurones using viral gene transfer.
Teschemacher AG; Paton JF; Kasparov S
Adv Drug Deliv Rev; 2005 Jan; 57(1):79-93. PubMed ID: 15518922
[TBL] [Abstract][Full Text] [Related]
13. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.
Breckpot K; Aerts JL; Thielemans K
Gene Ther; 2007 Jun; 14(11):847-62. PubMed ID: 17361214
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.
Dreyer JL
Methods Mol Biol; 2010; 614():3-35. PubMed ID: 20225033
[TBL] [Abstract][Full Text] [Related]
16. High-capacity 'gutless' adenoviral vectors.
Kochanek S; Schiedner G; Volpers C
Curr Opin Mol Ther; 2001 Oct; 3(5):454-63. PubMed ID: 11699889
[TBL] [Abstract][Full Text] [Related]
17. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
Pellinen R; Hakkarainen T; Wahlfors T; Tulimäki K; Ketola A; Tenhunen A; Salonen T; Wahlfors J
Int J Oncol; 2004 Dec; 25(6):1753-62. PubMed ID: 15547714
[TBL] [Abstract][Full Text] [Related]
18. Latest development in viral vectors for gene therapy.
Lundstrom K
Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368
[TBL] [Abstract][Full Text] [Related]
19. Dual-promoter lentiviral vectors for constitutive and regulated gene expression in neurons.
Gascón S; Paez-Gomez JA; Díaz-Guerra M; Scheiffele P; Scholl FG
J Neurosci Methods; 2008 Feb; 168(1):104-12. PubMed ID: 17983662
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
